• 1
    Salvarani C, Cantini F, Boiardi L, Hunder GG. Polymyalgia rheumatica and giant cell arteritis. N Engl J Med 2002; 347: 26171.
  • 2
    McGonagle D, Conaghan PG, O'Connor P, Gibbon W, Green M, Wakefield R, et al. The relationship between synovitis and bone changes in early untreated rheumatoid arthritis: a controlled magnetic resonance imaging study. Arthritis Rheum 1999; 42: 170611.
  • 3
    Conaghan PG, O'Connor P, McGonagle D, Astin P, Wakefield RJ, Gibbon WW, et al. Elucidation of the relationship between synovitis and bone damage: a randomized magnetic resonance imaging study of individual joints in patients with early rheumatoid arthritis. Arthritis Rheum 2003; 48: 6471.
  • 4
    Salvarani C, Cantini F, Olivieri I, Barozzi L, Macchioni L, Niccoli L, et al. Proximal bursitis in active polymyalgia rheumatica. Ann Intern Med 1997; 127: 2731.
  • 5
    Cantini F, Salvarani C, Olivieri I, Barozzi L, Macchioni L, Niccoli L, et al. Remitting seronegative symmetrical synovitis with pitting oedema (RS3PE) syndrome: a prospective follow up and magnetic resonance imaging study. Ann Rheum Dis 1999; 58: 2306.
  • 6
    McGonagle D, Pease C, Marzo-Ortega H, O'Connor P, Gibbon W, Emery P. Comparison of extracapsular changes by magnetic resonance imaging in patients with rheumatoid arthritis and polymyalgia rheumatica. J Rheumatol 2001; 28: 183741.
  • 7
    Tan AL, Tanner SF, Conaghan PG, Radjenovic A, O'Connor P, Brown AK, et al. Role of metacarpophalangeal joint anatomic factors in the distribution of synovitis and bone erosion in early rheumatoid arthritis. Arthritis Rheum 2003; 48: 121422.
  • 8
    Radjenovic A, Conaghan PG, Ridgway JP, O'Connor PJ, Meaney JF, Gibbon WW, et al. A fully automated method for measuring treatment efficacy in rheumatoid arthritis using quantitative analysis of dynamic Gd-DTPA enhanced MRI [abstract]. Arthritis Rheum 1999; 42 Suppl 9: S81.
  • 9
    Reece RJ, Kraan MC, Radjenovic A, Veale DJ, O'Connor PJ, Ridgway JP, et al. Comparative assessment of leflunomide and methotrexate for the treatment of rheumatoid arthritis, by dynamic enhanced magnetic resonance imaging. Arthritis Rheum 2002; 46: 36672.
  • 10
    Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 31524.
  • 11
    Bird HA, Esselinckx W, Dixon AS, Mowat AG, Wood PH. An evaluation of criteria for polymyalgia rheumatica. Ann Rheum Dis 1979; 38: 4349.
  • 12
    Ostergaard M, Peterfy C, Conaghan P, McQueen F, Bird P, Ejbjerg B, et al. OMERACT Rheumatoid Arthritis Magnetic Resonance Imaging Studies: core set of MRI acquisitions, joint pathology definitions and the OMERACT RA-MRI scoring system [published erratum appears in J Rheumatol 2004;31:198]. J Rheumatol 2003; 30: 13856.
  • 13
    McGonagle D, Gibbon W, O'Connor P, Green M, Pease C, Ridgway J, et al. An anatomical explanation for good-prognosis rheumatoid arthritis. Lancet 1999; 353: 1234.
  • 14
    Brown AK, Conaghan PG, Quinn MA, Karim Z, Wakefield RJ, Hensor EM, et al. The reliability of magnetic resonance imaging in the assessment of low disease activity rheumatoid arthritis [abstract]. Rheumatology (Oxford) 2006; 45 Suppl 1: i101.
  • 15
    Paice EW, Wright FW, Hill AG. Sternoclavicular erosions in polymyalgia rheumatica. Ann Rheum Dis 1983; 42: 37983.